The customer receipts is moving towards the right direction as...

The customer receipts is moving towards the right direction as expected and even slightly better than the common expectation I reckon. The fist step of commercialization has turned out to be successful. Not It's just a matter of timing thing to wait for the full rollout of IMed deal and PACT act deal. I don't think a capital raise by the end of next FY is a bad thing if there is one, as the business will probably need some additional cash to keep growing momentum at some stage, such as entering a new market, investing in R&D, etc. I believe that the share price will be much higher than the current level so the dilution will be much less than our expectation.